Correlation Between Neurobo Pharmaceuticals and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and ZyVersa Therapeutics, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and ZyVersa Therapeutics.
Diversification Opportunities for Neurobo Pharmaceuticals and ZyVersa Therapeutics
0.74 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Neurobo and ZyVersa is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and ZyVersa Therapeutics
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 0.52 times more return on investment than ZyVersa Therapeutics. However, Neurobo Pharmaceuticals is 1.92 times less risky than ZyVersa Therapeutics. It trades about -0.07 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.08 per unit of risk. If you would invest 400.00 in Neurobo Pharmaceuticals on August 27, 2024 and sell it today you would lose (158.00) from holding Neurobo Pharmaceuticals or give up 39.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurobo Pharmaceuticals vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Neurobo Pharmaceuticals |
| ZyVersa Therapeutics |
Neurobo Pharmaceuticals and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurobo Pharmaceuticals and ZyVersa Therapeutics
The main advantage of trading using opposite Neurobo Pharmaceuticals and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |